Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes
OBJECTIVE - To examine the dose-related pharmacodynamics and pharmacokinetics of a single preprandial oral dose of repaglinide in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS - A total of 16 Caucasian men with type 2 diabetes participated in two placebo-controlled double-blind randomiz...
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
2000
|
Subjects: |